Skip to main content

Editorial Board

Editors-in-Chief
Dr Franco M Buonaguro, Istituto Nazionale Tumori “Fond. G. Pascale”, Naples, Italy
Dr Sam M Mbulaiteye, National Cancer Institute, Bethesda, MD, USA
Dr Maria Lina Tornesello, Istituto Nazionale Tumori “Fond. G. Pascale”, Naples, Italy

Section Editors
Clinical oncology
Prof Serigne Magueye Gueye, General Hospital of Grand-Yoff, Dakar, Senegal
Prof Jan Vermorken, University Hospital Antwerp, Belgium

African cancers
Prof Twalib Ngoma, Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Prof Henry R Wabinga, Makerere University, Kampala, Uganda

Cancer centers in low- and middle-income countries
Dr Kishor Bhatia, National Cancer Institute, Bethesda, MD, USA

Advisory Board
Prof Arséne Burny, University of Brussels, Belgium
Prof Ethel-Michele de Villiers, German Cancer Research Center, Heidelberg, Germany
Prof Volker Erfle, Institute for Molecular Virology, Ulm, Germany
Dr Silvia Franceschi, International Agency for Research on Cancer, Lyon, France
Prof Robert Gallo, University of Maryland, Baltimore, MD, USA
Dr Denise DG Galloway, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Prof Eva Klein, Karolinska Institute, Stockholm, Sweden
Prof Jay Nelson, Oregon Health & Sciences University, Portland, OR, USA
Prof Joseph S Pagano, University of North Carolina, Chapel Hill, NC, USA
Prof Giorgio Palu, University of Padua, Italy
Prof Bernard Roizman, University of Chicago, Chicago, IL, USA

Editorial Board
Dr Francisco Aguayo, University of Chile, Santiago, Chile
Prof Niyaz Ahmed, University of Hyderabad, Telangana, India
Dr Adriana Albini, IRCCS Multimedica, Milan, Italy
Prof Richard Ambinder, John Hopkins University, Baltimore, MD, USA
Prof Charles Bangham, Imperial College London, UK
Dr Filippo Belardelli, Istituto Superiore di Sanità, Rome, Italy
Prof Valerie Beral, University of Oxford, UK
Prof Luigi Buonaguro, Istituto Nazionale Tumori, Naples, Italy
Prof Yuan Chang, University of Pittsburgh Cancer Institute, PA, USA
Prof Massimo Clementi, Vita-Salute San Raffaele University, Italy
Dr. Valli De Re, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy
Dr Paola Di Bonito, Istituto Superiore di Sanità, Rome, Italy
Dr Riccardo Dolcetti, Centro di Riferimento Oncologico, Aviano, Italy
Prof Reza Farid, University of Mashhad, Iran
Dr Renato Franco, University of Campania Luigi Vanvitelli, Caserta, Italy
Marisa Gariglio, University of Eastern Piedmont, Novara, Italy
Dr Tarik Gheit, International Agency for Research on Cancer, Lyon, France
Dr Paolo Giorgi Rossi, IRCCS di Reggio Emilia, Italy
Prof Wenlin Huang, Sun Yat-sen University, Guangzhou, China
Dr Tetsuya Ikeda, Kyorin University, Tokyo, Japan
Prof Shuji Izumo, Kagoshima University, Japan
Dr Steven Jacobson, Viral Immunology Section, National Institutes of Health, Bethesda, MD, USA
Prof Andrei Kozlov, St Petersburg State University, Russia
Prof Hung-Jen Liu, National Chung Hsing University, Taichung, Taiwan
Prof Lucia Lopalco, San Raffaele Scientific Institute, Milan, Italy
Dr Rubén López-Revilla, Instituto Potosino de Investigación Científica y Tecnológica, San Luis Potosí, Mexico
Prof Dr Luiz Fernando Almeida Machado, Federal University of Pará, Belém, Brazil
Prof Alberto Mantovani, University of Milan, Italy
Dr Enrique A. Mesri, University of Miami and Sylvester Comprehensive Cancer Center, Miami, FL, USA
Prof Ponsiano Ocama, Makerere University College of Health Science, Kampala, Uganda
Dr Maurizio Provenzano, University Hospital of Zurich, Switzerland
Dr Camille Ragin, Fox Chase Cancer Center, Philadelphia, PA, USA
Dr Mihir S Rajurkar, Harvard Medical School, Boston, MA, USA
Dr Brian Salmons, Austrianova, Singapore, Singapore
Prof Thomas Schulz, University of Hannover, Hanover, Germany
Prof Freddy Sitas, The University of Sydney, Australia
Prof Claudio Tiribelli, Fondazione Italiana Fegato, Trieste, Italy
Dr Aldo Venuti, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Dr Huizhi Wang, Virginia Commonwealth University, Richmond, VA, USA
Dr Yoshihiko Yano, Kobe University Graduate School of Medicine, Kobe, Japan
Dr Robert Yarchoan, HIV and AIDS Malignancy Branch, National Institutes of Health, Bethesda, MD, USA
Prof Jian-Hong Zhong, Guangxi Medical University, Nanning, China
Prof Axel zur Hausen, Maastricht University Medical Centre+, The Netherlands

Annual Journal Metrics